Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramyometrial vs continuous intravenous oxytocin during elective cesarean section
jRCTs041210153Completed
- Start
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin (2 arms). Primary endpoint: Total blood loss from intraoperative period to 2 hours after returning to the ward. Started Apr 2022; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on jRCTs041210153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210153.